Great post Danny - $50 reasonable by years end IF they hit the targeted onjectives, any shot at $2B is certainly a blackswan into the distant future you only have to look at peers in business model Galapagus, Evototec etc to see their market caps is still nowhere near that after being around for much longer & with drugs in clinic there all around the $300-$500M mark & earning signifcant revenues. The blackswan however if it does appear down the track will be on the library as a whole imo not an individual candidate.
Onshow while that bit is what we like to hear & hope is happening in the background it's still yet to materialize - it's soley what's coming out of managements mouths ?
"Good to see these big boys coming back to us for more deals"
PYC Price at posting:
2.2¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)